Loading
IARC estimates 2,103 new cancer cases and 882 cancer deaths in Bahrain in 2024; the commonest new cancers are breast, colorectum and bladder. This page is assembled automatically from OnCo's data: 1 institution and 1 person, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 433 | 67.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 228 | 17.1 | Colorectal cancer |
| Bladder | 152 | 12.6 | Bladder & urothelial cancer |
| Trachea, bronchus and lung | 115 | 10.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Corpus uteri | 113 | 20.0 | Endometrial cancer |
| Thyroid | 103 | 5.1 | Thyroid cancer |
| Non-Hodgkin lymphoma | 102 | 7.1 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Prostate | 87 | 15.5 | Prostate cancer |
| Leukaemia | 70 | 5.2 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Testis | 67 | 4.1 | Testicular germ cell tumours |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 118 | 19.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 101 | 8.1 | Colorectal cancer |
| Trachea, bronchus and lung | 101 | 9.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Liver and intrahepatic bile ducts | 58 | 5.1 | Hepatocellular carcinoma |
| Bladder | 56 | 4.9 | Bladder & urothelial cancer |
| Leukaemia | 47 | 3.7 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Pancreas | 35 | 2.9 | Pancreatic ductal adenocarcinoma |
| Non-Hodgkin lymphoma | 34 | 2.5 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Ovary | 33 | 5.6 | Ovarian cancer |
| Stomach | 31 | 2.7 | Gastric & gastro-oesophageal junction cancer |
No trial record in OnCo lists a site in Bahrain. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
People whose main affiliation in OnCo is an institution or company in Bahrain.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Bahrain is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Bahrain is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.